Tahir Siddique, Sadaf Farzand, Marryam Khalid, Rizwan Ahmad, Kashif Aziz Ahmad, & Muhammad Maqsood. (2025). Efficacy and Safety of Once-Weekly Semaglutide versus Tirzepatide in Type 2 Diabetes: A 24-Week Randomized Clinical Trial. Journal of Health, Wellness and Community Research, 3(1), 1-8. https://doi.org/10.61919/qxt0b644